Oops




$2.29T
Total marketcap
$126.47B
Total volume
BTC 49.71%   •   ETH 15.77%
Dominance

Corline Biomedical AB CLBIO.ST Stock

11.3 SEK {{ price }} -3.829785% {{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Biotechnology
COUNTRY
Sweden
Exchange
Stockholm
Market Cap
242.85M SEK
LOW - HIGH [24H]
11.25 - 11.75 SEK
VOLUME [24H]
12.82K SEK
{{ volume }}
P/E Ratio
0
Earnings per share
-0.04 SEK

Corline Biomedical AB Price Chart

Corline Biomedical AB CLBIO.ST Financial and Trading Overview

Corline Biomedical AB stock price 11.3 SEK
Previous Close 14.45 SEK
Open 14.85 SEK
Bid 15.1 SEK x 0
Ask 15.5 SEK x 0
Day's Range 14.85 - 16.3 SEK
52 Week Range 7.6 - 19.85 SEK
Volume 3.96K SEK
Avg. Volume 23.03K SEK
Market Cap 333.11M SEK
Beta (5Y Monthly) 0.634099
PE Ratio (TTM) 77.5
EPS (TTM) -0.04 SEK
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A

CLBIO.ST Valuation Measures

Enterprise Value 306.82M SEK
Trailing P/E 77.5
Forward P/E 2.8703704
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 8.681228
Price/Book (mrq) 3.4839292
Enterprise Value/Revenue 7.996
Enterprise Value/EBITDA 71.905

Trading Information

Corline Biomedical AB Stock Price History

Beta (5Y Monthly) 0.634099
52-Week Change 27.87%
S&P500 52-Week Change 20.43%
52 Week High 19.85 SEK
52 Week Low 7.6 SEK
50-Day Moving Average 13.06 SEK
200-Day Moving Average 10.29 SEK

CLBIO.ST Share Statistics

Avg. Volume (3 month) 23.03K SEK
Avg. Daily Volume (10-Days) 14.21K SEK
Shares Outstanding 21.49M
Float 7.73M
Short Ratio N/A
% Held by Insiders 54.87%
% Held by Institutions 14.21%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 10.94%
Operating Margin (ttm) 10.94%
Gross Margin 72.59%
EBITDA Margin 11.11%

Management Effectiveness

Return on Assets (ttm) 2.61%
Return on Equity (ttm) 4.49%

Income Statement

Revenue (ttm) 38.37M SEK
Revenue Per Share (ttm) 1.79 SEK
Quarterly Revenue Growth (yoy) 130.69%
Gross Profit (ttm) 22.73M SEK
EBITDA 4.27M SEK
Net Income Avi to Common (ttm) 4.2M SEK
Diluted EPS (ttm) 0.2
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 19.84M SEK
Total Cash Per Share (mrq) 0.92 SEK
Total Debt (mrq) 0 SEK
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) 4.431
Book Value Per Share (mrq) 4.449

Cash Flow Statement

Operating Cash Flow (ttm) -5122000 SEK
Levered Free Cash Flow (ttm) -17345000 SEK

Profile of Corline Biomedical AB

Country Sweden
State N/A
City Uppsala
Address Lefflersgatan 5
ZIP 754 50
Phone 46 18 71 30 90
Website https://www.corline.se
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 12

Corline Biomedical AB develops, manufactures, and markets heparin based solutions to enhance kidney transplantation, cell therapies, and regenerative medicine applications. Its products are based on Corline Heparin Conjugate (CHC) technology, a heparin conjugate that is used as stand-alone pharmaceutical compound. The company's products include Renaparin for use in the treatment of end stage renal failure; Cytoparin, a cell therapy that is used for the treatment of patients with type 1 diabetes; CHC, which is used for the treatment of soft tissue injuries; medical devices; and CHS, a coronary stent use for the treatment of acute or threatened vessel closure during coronary angioplasty. The company was incorporated in 1991 and is based in Uppsala, Sweden.

Q&A For Corline Biomedical AB Stock

What is a current CLBIO.ST stock price?

Corline Biomedical AB CLBIO.ST stock price today per share is 11.3 SEK.

How to purchase Corline Biomedical AB stock?

You can buy CLBIO.ST shares on the Stockholm exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Corline Biomedical AB?

The stock symbol or ticker of Corline Biomedical AB is CLBIO.ST.

Which industry does the Corline Biomedical AB company belong to?

The Corline Biomedical AB industry is Biotechnology.

How many shares does Corline Biomedical AB have in circulation?

The max supply of Corline Biomedical AB shares is 21.49M.

What is Corline Biomedical AB Price to Earnings Ratio (PE Ratio)?

Corline Biomedical AB PE Ratio is now.

What was Corline Biomedical AB earnings per share over the trailing 12 months (TTM)?

Corline Biomedical AB EPS is -0.04 SEK over the trailing 12 months.

Which sector does the Corline Biomedical AB company belong to?

The Corline Biomedical AB sector is Healthcare.

Corline Biomedical AB CLBIO.ST included in indexes

Name Name Price Price 24h%
7d chart 24h% & 7d 		VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart 24h% & 7d 		VOL Volume 24h low 24h high Volume
{{ item.name }} {{ item.symbol }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
First North Sweden EUR GI FNSEEURGI 1570.14 EUR 1716.38 USD
-0.77
— — — — — — — — —
First North Health Care GI FN20GI 917.04 EUR 1002.44 USD
-1.17
— — — — — — — — —
First North All-Share EUR FIRSTNORTHEUR 97.9 EUR 107.01 USD
-0.64
— — — — — — — — —
First North Sweden SEK PI FNSESEKPI 1843.91 SEK 179.99 USD
-0.28
— — — — — — — — —
First North Sweden EUR PI FNSEEURPI 1479.5 EUR 1617.29 USD
-0.77
— — — — — — — — —
First North Health Care PI FN20PI 912.9 EUR 997.92 USD
-1.17
— — — — — — — — —
First North All-Share SEK FIRSTNORTHSEK 123.34 SEK 12.04 USD
-0.14
— — — — — — — — —
First North All-Share DKK FIRSTNORTHDKK 97.96 DKK 14.36 USD
-0.62
— — — — — — — — —
First North Sweden SEK GI FNSESEKGI 1956.89 SEK 191.02 USD
-0.28
— — — — — — — — —

Stocks Related By Sector

Stocks Related By Industry

Stocks Related By Marketcap